Mytide Therapeutics

Mytide has digitized the production of synthetic peptides and proteins. Our technology is 30x faster and provides access to trillions of new molecules.

  • Stage Product In Market
  • Industry Biotechnology
  • Location Boston, MA, USA
  • Currency USD
  • Founded June 2018
  • Employees 10
  • Incorporation Type C-corp

Company Summary

Mytide is focused on the digitization of peptide-based scaffolds by leveraging robotics, machine learning, and continuous manufacturing. Our platform allows us to make them 30x faster, directly scalable, and with a 4x lower production cost. Peptides represent one of the most promising next-generation treatments in oncology, infectious, and autoimmune disease areas. .

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free